Upgrade to SI Premium - Free Trial

Merck (MRK) PT Raised to $138 at Jefferies

March 30, 2026 4:11 PM
Jefferies analyst Akash Tewari raised the price target on Merck (NYSE: MRK) to $138.00 (from $132.00) while maintaining a Buy ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change